Streetbeat News

Equity Actions

DAL

DDD

JCI

LYFT

MMM

SPCE

UBER

VRT

Today's session highlighted significant options activity for 10 industrials stocks, indicating potential trading opportunities based on whale alerts. These alerts track large transactions, suggesting shifts in market sentiment for stocks like GE, LYFT, JCI, DDD, MMM, BA, VRT, SPCE, UBER, and DAL. The activity varied from bullish to bearish sentiments across different expiration dates and strike prices, reflecting diverse market expectations.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 5:35 pm

AAPL

AMD

NVDA

PLTR

Today's session highlighted significant whale activity in the options market for 10 Information Technology stocks, indicating potential trading opportunities. Notable bullish sentiment was observed in NVDA, AMD, MARA, SMCI, GDDY, and IREN through call trades, while bearish sentiment was seen in AAPL, PLTR, and ENPH with put sweeps. ARM experienced a call sweep with bearish sentiment. The activity suggests varying investor expectations on these stocks' future movements.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 5:35 pm

QRTEA

Michael Burry has taken a new position in Qurate Retail, purchasing 600,000 shares, as revealed in a 13F filing.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 5:32 pm

TWLO

Joe Terranova announced live on CNBC that he has sold his position in Twilio (TWLO).

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 5:18 pm

ROIV

Roivant Sciences (NASDAQ:ROIV) received mixed analyst ratings with an average 12-month price target of $15.75, reflecting an 8.62% increase from the previous target. The company showed significant revenue growth of 196.03% as of September 30, 2023, but struggles with profitability and efficiency, indicated by a net margin of -820.27%, ROE of -32.74%, and ROA of -14.48%. Its debt-to-equity ratio stands at 0.52, below industry average.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 5:01 pm

GMAB

Genmab A/S (NASDAQ:GMAB) has announced the initiation of a share buy-back program to repurchase up to 190,000 shares from February 15, 2024, to March 15, 2024. The program aims to honor commitments under the Restricted Stock Unit program. Danske Bank will act as the lead manager, making trading decisions independently of Genmab. The buy-back will adhere to the Safe Harbour Regulation, with purchases not exceeding 25% of the average daily trading volume on Nasdaq Copenhagen over the preceding 20 trading days. As of February 14, 2024, Genmab holds 735,891 treasury shares, representing 1.11% of the share capital.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 4:42 pm

OMH

Ohmyhome's stock price has declined following the announcement of an upsized public offering valued at $4.8 million.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 4:25 pm

SFWL

Changle International Limited has reported a 9.6% stake in Shengfeng Development (SFWL) as of December 31, 2023, according to a 13G filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 4:22 pm

ENGN

enGene announced an oversubscribed $200 million private placement financing, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 4:21 pm

DIS

Trian Group, owning $3.5 billion of Disney stock, urges shareholders to vote for its nominees, Nelson Peltz and Jay Rasulo, to improve Disney's performance. Disney's recent strategies, including a $1.5 billion investment and a sports streaming venture, have not improved shareholder returns, with the stock price and earnings estimates declining. Trian criticizes Disney's lack of a clear plan and calls for new independent directors to ensure accountability and strategic focus.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 4:18 pm